Excelsior Medical Co., Ltd. · TWSE:4104

Excelsior Medical — Investor Conference 2025/8/22

19 slides from Excelsior Medical's conference presentation, Aug 22, 2025

  1. Slide 1: Excelsior Medical Co., Ltd. Investor Conference

    Excelsior Medical Co., Ltd. Investor Conference 2025/8/22

  2. Slide 2: Disclaimer

    Disclaimer This presentation is prepared according to the audited or reviewed financial statements by CPA and the financial figures hereby are based on IFRS, please refer to the published financial statements for full content. The presentation may contain forward-looking information and may differ m

  3. Slide 3: The Business Types

    The Business Types Hemodialysis Aesthetic Medical Trading Business Medical Devices Medical Consumables Home Appliances Product Planning Sales Information Analysis Promotion Hemodialysis channel Pharma. Sales and Promotion Market Creative Aesthetic Medical channel Pharma. Distribution and Logistics M

  4. Slide 4: Revenue Overview

    Revenue Overview Excelsior yearly consolidated sales is more than NT $ 8.5 billion in 2024, the primary revenue comes from Excelsior (Hemodialysis), Dynamic (Aesthetic Medical), Arich (Pharmaceutical Logistics) and others. According to the company’s function, the business type can be characterized a

  5. Slide 5: Operating Overview

    Operating Overview Unit: NTD in thousands 5

  6. Slide 6: Investment Overview

    Investment Overview Unit: NTD in thousands 6

  7. Slide 7: Profit after Tax Overview

    Profit after Tax Overview Unit: NTD in thousands/ EPS: NTD in Dollars 7

  8. Slide 8: Balance Sheet

    Excelsior Healtheare Group fa) eke Balance Sheet Unit: In thousands NTD 2023125318 20242F12A318 20256A308 Current Assets: 2,614,786 4,189,204 2,324,907 1,961,336 1,945,932 1,980,811 3,853,342 3,661,059 3,751,801 |_lnventories 1,247,430 1,392,801 1,320,184 1,014,936 1,031,944 831,168 10,691,830 12,22

  9. Slide 9: Balance Sheet

    Balance Sheet 1,134,887 917,531 822,216 974,726 978,970 1,058,284 3,464,888 5,307,269 3,619,937 1,104,256 1,084,891 1,073,710 6,678,757 8,288,661 6,574,147 : ; 350,000 488,209 721,987 701,505 488,209 721,987 1,051,505 7,166,966 9,010,648 7,625,852 1,856,167 1,633,975 1,633,975 : : 81,699 3,267,576 3

  10. Slide 10: Statement of Comprehensive Income

    Statement of Comprehensive Income 10

  11. Slide 11: Statements of Cash Flows

    ee Excelsior Healtheare Group a+ Statements of Cash Flows [Unit:In thousands NTD.C—C—“‘é~*SCSCi‘i ST | 02s 1,144,080 1,174,362 629,304 [Adjustments (164,775) (99,191) (107,335) (244,183) 16,289 (396) (642,241) 199,157 (99,816) (139,988) (264,071) 26,427 (26,530) 4,244 79,314 248,708 1,661,961 (1,687

  12. Slide 12: Statements of Cash Flows

    Statements of Cash Flows Unit: In thousands _NTD re Acquisition of financial assets at fair value through profit or loss Proceeds from disposal of financial assets at fair value through profit or loss Acquisition of financial assets at fair value through other comprehensive income Proceeds from disp

  13. Slide 13: Statements of Cash Flows

    Statements of Cash Flows 599,753 (217,356) (95,315) : - 350,000 (540,953) (591,344) (620,910) Proceeds from disposal of ownership interests in a : 47,736 159,086 subsidiaries (Not losing control (211,048) (306,342) (234,576) Net Cash Flows used in Financing Activities (104,512) (955,956) (600,801) E

  14. Slide 14: Sustainability Report

    =e8 Excelsior Healtheare Group FT) (es (ee gs 2024 KR Sustainability Report A eS Dh RRS EM LBM BIAS) sO 14064-1:2018 Sustainability Report y a AAI000 Licensed Report (000-250/V2-J628U eA WW): 14

  15. Slide 15: Concrete ESG Implementation Results

    Concrete ESG Implementation Results 1.In 2023, our company successfully completed the ISO 14064-1 GHG inventory and assurance status ahead of schedule. We will continue to promote the completion of GHG inventories across all subsidiaries within the group. 2.In 2023, our company implemented a smart e

  16. Slide 16: Concrete ESG Implementation Results

    Concrete ESG Implementation Results 1.In 2023, we visited Taipei Zhaoru Senior Care Center to accompany the elderly in a dumpling-making event. In 2024, we organized a Dragon Boat Festival rice dumpling-making activity at Zhongli Smart Aging Academy for seniors with dementia and a recreational event

  17. Slide 17: Concrete ESG Implementation Results

    Concrete ESG Implementation Results 1.In 2022, we published our first Sustainability Report. In 2023, we emphasized SASB (Sustainability Accounting Standards Board) and TCFD (Task Force on Climate-Related Financial Disclosures) standards. 2.In 2023, we established the Sustainability Development Comm

  18. Slide 18: Growing up with Long-term partners

    Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate various professional medical fields. Excelsior will keep taking root in the Asia market, the business scope includes Taiwan, Hong Kong, China

  19. Slide 19: Growing up with Long-term partners

    Growing up with Long-term partners Excelsior has been operating for 30 years, accumulated core competitiveness with new ideas created, new models to integrate variously professional medical fields. Excelsior will keep take root in the Asia market, the business scope includes Taiwan, Hong Kong, China

Excelsior Medical — Investor Conference 2025/8/22 on 6ix